Capio Biosciences

Biotech

[Capio Biosciences @capiobio]

Capio Biosciences and BioView have launched a $2.18M project to advance the use of liquid biopsy for head and neck cancer with a new study in Korea. The project is supported with a $874,000 grant from the Korea-Israel (KORIL) Industrial R&D Foundation.

[Capio Biosciences @capiobio]

Capio Biosciences was highlighted by the Wisconsin State Journal in an article describing companies and laboratories in Madison working to develop #liquidbiopsy https://t.co/mCxvAuhgVg via @WiStateJournal

[Capio Biosciences @capiobio]

Capio Biosciences, BioView to Explore Integration of Circulating Tumor Cell Technologies https://t.co/Ppraw43D48

[Capio Biosciences @capiobio]

Pleased to announce that Seungpyo Hong PhD, PSD Professor, Director of Wisconsin Center for NanoBioSystems and cofounder of Capio Biosciences, will become the first to be named to the newly endowed Milton J. Henrichs chair position. #capiobio, #biomarkers https://t.co/YJ9v6cMPFk

[Capio Biosciences @capiobio]

Congratulations to Mike Poellmann and the Capio team for a new article featuring CapioCyte™ technology for exosome capture published in Nano Letters. https://t.co/RKwR5MTzqu Expanding choice of biomarkers, enabling our liquid biopsy technology to more accurately detect cancer!

[Capio Biosciences @capiobio]

Congratulations Mike!

[Michael Poellmann @m_poellmann]

Very happy to finally see this work published! We developed a nanostructured polymer surface for exosome-based liquid biopsy, and used AFM to provide mechanistic insight into how dendrimers contribute to biomarker capture.
https://t.co/mJ4WMtOTWI

[Kent DeLay @kjdelay1]

Currently having a patient refusing to keep his mask on saying we are denying his constitutional rights, I am so tired of American individualism and assholism. He is refusing to leave. #Covid #dontbeanasshole

[Capio Biosciences @capiobio]

New article featuring CapioCyte™ has been published in Biosensors and Bioelectronics. To view the abstract click https://t.co/k4OKgJG1Lb
@capiobio
#biomarkers #CirculatingTumorCells

[Capio Biosciences @capiobio]

New article featuring CapioCyte™ has been published in Biosensors and Bioelectronics. To view the abstract click https://t.co/k4OKgJG1Lb @capiobio #biomarkers #CirculatingTumorCells

[Capio Biosciences @capiobio]

Professor Seungpyo Hong's work with Capio Biosciences is one of six faculty projects getting a boost from State Economic Engagement and Development (SEED) funding through UW–Madison's Discovery to Product group. https://t.co/eJNwkOwkwZ @capiobio, #biomarkers #CTC

[Forward BIO Institute @Forward_BIO]

Seungpyo Hong (@UWMadPharmacy Prof of Pharmaceutical Sciences ) will work with @capiobio to develop a liquid biopsy test that uses nanotechnology to detect the presence of cancer in the body through a minimally invasive blood draw.

[Capio Biosciences @capiobio]

Capio Biosciences is pleased to announce receipt of an official Notice of Allowance for U.S. Patent Application Serial No.: 15/123,156 - "Biomimetic Microfluid Device for Capturing Circulating Tumor Cells” from USPTO. #circulatingtumorcells, #biomarkers, #precisionmedicine

[Capio Biosciences @capiobio]

Capio Biosciences receives QNBV Certification from Wisconsin Economic Development Corporation (WEDC) allowing qualified Wisconsin-based investors to receive a tax credit equal to 25 percent of the value of their investment in Capio. @WEDCNews #Biomarkers, #CirculatingTumorCells

[Capio Biosciences @capiobio]

Capio Biosciences receives QNBV Certification from Wisconsin Economic Development Corporation (WEDC) allowing qualified Wisconsin-based investors to receive a tax credit equal to 25 percent of the value of their investment in Capio. @WEDCNews #Biomarkers, #CirculatingTumorCells

[Capio Biosciences @capiobio]

Today's the day! Andrew Wang MD, Assoc. Prof., Dept. of Radiation Oncology, UNC and Cofounder of Capio Biosciences​ will present our CapioCyte™ Technology on January 22nd at PMWC 2020. https://t.co/DB8vNsffO5
@capiobio @PMWCintl #biomarkers #oncology #CirculatingTumorCells

[Capio Biosciences @capiobio]

Just over a week until Andrew Wang MD, Assoc. Prof., Dept. of Radiation Oncology, UNC and Cofounder of Capio Biosciences​ will present our CapioCyte™ Technology on January 22nd at PMWC 2020. https://t.co/Uq7gyVSFLq @capiobio @PMWCintl #biomarkers #oncology #CirculatingTumorCells

[Capio Biosciences @capiobio]

Presenting at PMWC 2020
Very excited that Andrew Wang MD, Assoc. Prof., Dept. of Radiation Oncology, UNC and Cofounder of Capio Biosciences​ will present our CapioCyte™ Technology on January 22nd at PMWC 2020. https://t.co/13kpo8BuQH @capiobio @PMWCintl #biomarkers #oncology

[Capio Biosciences @capiobio]

Did you know that Capio Biosciences was recently recognized by StartUpCity magazine as one of the most promising 15 Biotech startups 2019? https://t.co/kHiI4RAtAb
@capiobio, #startupcity, #circulatingtumorcells, #biomarkers

[Capio Biosciences @capiobio]

Capio Biosciences is pleased to be recognized by StartUpCity magazine as one of the most promising 15 Biotech startups 2019, and for being at the forefront of the biotech industry. https://t.co/qHryzNm18M @capiobio #startupcity, #circulatingtumorcells

[Capio Biosciences @capiobio]

Capio Biosciences is pleased to be recognized by StartUpCity magazine as one of the most promising 15 Biotech startups 2019, and for being at the forefront of the biotech industry. https://t.co/qHryzNm18M @capiobio #startupcity, #circulatingtumorcells